CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%. Despite this poor prognosis, SCLC is initially highly responsive to ...

Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of small cell lung cancer. Small cell lung cancer (SCLC) is among the most ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

One of the ways scientists are trying to improve cancer treatments is by better equipping the body's own immune system to ...

Why does cancer sometimes recur even after successful treatment, or why do some bacteria survive despite the use of powerful ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...

New research has revealed that a single session of weight training can help fight breast cancer. Researchers at Edith Cowan University in Australia investigated how resistance training and ...